A Step Forward in Hypervirulent Klebsiella pneumoniae Diagnostics

Area of Science:

• Microbiology
• Infectious Diseases
• Bacteriology

Background:

• Hypervirulent Klebsiella pneumoniae (hvKp) causes severe, life-threatening infections in healthy individuals.
• HvKp infections can manifest in unusual sites like the central nervous system and eyes, differing from classical K. pneumoniae (cKp).
• Antimicrobial resistance acquisition by hvKp raises concerns about a emerging superbug, amplified by global spread and healthcare-associated infections.

Purpose of the Study:

• To address the lack of diagnostic tests differentiating hvKp from cKp.
• To propose a working definition for hvKp to improve diagnostic and surveillance accuracy.
• To aid in the prevention of hvKp dissemination.

Main Methods:

• Reviewing existing literature and diagnostic approaches for Klebsiella pneumoniae.
• Evaluating the efficacy of detecting specific biomarkers (iucA, iroB, peg-344, rmpA, and rmpA2) for hvKp identification.
• Proposing a pragmatic definition for hvKp based on biomarker detection.

Main Results:

• Currently, no definitive diagnostic test exists to distinguish hvKp from cKp.
• Detection of all five biomarkers (iucA, iroB, peg-344, rmpA, and rmpA2) is the most accurate available method for hvKp identification.
• This biomarker panel serves as a pragmatic approach for clinical care, surveillance, and research.

Conclusions:

• A clear definition for hvKp is needed to enhance diagnostic and surveillance accuracy.
• The proposed working definition based on biomarker detection can help mitigate the spread of hvKp.
• Improved identification of hvKp is crucial for managing this emerging public health threat.